MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype

T Cell Leukemia/Lymphoma 1 and Galectin-1 Regulate Survival/Cell Death Pathways in Human Naive and IgM+ Memory B Cells through Altering Balances in Bcl-2 Family Proteins

(2014) S. J. Tabrizi et al.   JOURNAL OF IMMUNOLOGY

MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2

(2011) Ji-guang Zhang et al.   Journal of Thoracic Oncology

EZH2 Y641 mutations in follicular lymphoma

(2011) C Bödör et al.   LEUKEMIA

microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma

(2010) J.-J. Zhao et al.   BLOOD

The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia

(2010) Ulf Klein et al.   CANCER CELL

Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer

(2010) B. Zhang et al.   CARCINOGENESIS

Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis

(2010) Ying Xin WANG et al.   Journal of Digestive Diseases

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

(2010) Satoshi Shimizu et al.   JOURNAL OF HEPATOLOGY

Chk1 suppressed cell death

(2010) Mark Meuth   Cell Division

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

(2009) E. Leich et al.   BLOOD

Patterns of microRNA expression characterize stages of human B-cell differentiation

(2009) Jenny Zhang et al.   BLOOD

MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity

(2009) H. Su et al.   CANCER RESEARCH

Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas

(2009) Eri Hiroki et al.   CANCER SCIENCE

New Hope for a MicroRNA Therapy for Liver Cancer

(2009) John J. Rossi   CELL

MYC stimulates EZH2 expression by repression of its negative regulator miR-26a

(2008) S. Sander et al.   BLOOD

MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas

(2008) Anja Roehle et al.   BRITISH JOURNAL OF HAEMATOLOGY

Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression

(2008) E. Gagyi et al.   HAEMATOLOGICA

MicroRNA-26a Targets the Histone MethyltransferaseEnhancer of Zeste homolog 2during Myogenesis

(2008) Chung Fai Wong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

microRNA expression in lymphoid malignancies: new hope for diagnosis and therapy?

(2008) Charles Henderson Lawrie   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma

(2008) Charles H. Lawrie et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

TCL1A expression delineates biological and clinical variability in B-cell lymphoma

(2008) Mohit Aggarwal et al.   MODERN PATHOLOGY

Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

(2008) S. Varambally et al.   SCIENCE